Withdrawal of Registration Statement (rw)
August 15 2017 - 5:02PM
Edgar (US Regulatory)
Pressure
BioSciences, Inc.
14
Norfolk Avenue
South
Easton, MA 02375
August
15, 2017
VIA
EDGAR
Amanda
Ravitz, Assistant Director
Office
of Electronics and Machinery
Mail
Stop 3030
Division
of Corporation Finance
Securities
and Exchange Commission
100
F Street N.E.
Washington,
D.C. 20549
|
Re:
|
Pressure
BioSciences, Inc. (the “Company”)
|
|
|
Registration
Statement on Form S-1 (File No. 333-215277)
and
Form 8-A (File No. 001-38185)
|
Ladies
and Gentlemen:
Pursuant
to Rule 477 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), the Company hereby respectfully
requests that the U.S. Securities and Exchange Commission (the “Commission”) consent to the withdrawal, effective
as of the date hereof or at the earliest practicable date hereafter, of the Company’s Registration Statement on Form S-1
(File No. 333-215277), together with all exhibits thereto, initially filed with the Commission on December 22, 2016, as subsequently
amended on April 11, 2017, June 16, 2017, June 28, 2017, June 29, 2017, and August 10, 2017 (the “Registration Statement”).
The
Company has determined at this time not to proceed with the offering due to market conditions and requests that the Commission
consent to this application on the grounds that withdrawal of the Registration Statement is consistent with the public interest
and the protection of investors, as contemplated by paragraph (a) of Rule 477 under the Securities Act. The Company may undertake
a subsequent private offering in reliance on Rule 155(c) of the Securities Act.
The
Registration Statement was not declared effective and no securities were issued or sold pursuant to the Registration Statement.
In accordance with Rule 457(p) under the Securities Act, the Company requests that all fees paid to the Commission in connection
with the filing of the Registration Statement be credited as an offset to the filing fees for future registration statements.
In addition, the Registrant requests that the Commission consent to the withdrawal of the Registrant’s registration statement
on Form 8-A (File No. 001-38185), filed with the Commission on August 10, 2017, with such request to be approved effective as
of the date hereof or at the earliest practicable date hereafter.
Respectfully,
|
|
|
|
Pressure
BioSciences, Inc.
|
|
|
|
By:
|
/s/
Richard T. Schumacher
|
|
Name:
|
Richard
T. Schumacher
|
|
Title:
|
Chief
Executive Officer
|
|
Pressure Biosciences (CE) (USOTC:PBIO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Pressure Biosciences (CE) (USOTC:PBIO)
Historical Stock Chart
From Sep 2023 to Sep 2024